Clinical Trial Update: Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease [Phase 3]

View source ↗

Summary

Amgen is conducting a Phase 3 pediatric trial of apremilast for active oral ulcers in children with Behçet disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Behçet Disease | Phase 3 | Status: RECRUITING